HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Hexarelin Acetate |
|---|---|
| CAS number | 208251-52-9 (acetate salt; free base 140703-51-1) |
| Molecular formula | C47H58N12O6 (net peptide free base; mono-acetate salt C49H62N12O8, i.e. C47H58N12O6·CH3COOH) |
| Molecular weight | ≈ 887.06 g/mol (net peptide free base); mono-acetate salt ≈ 947.11 g/mol |
| Sequence | His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 2mg / 5mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Supply form: lyophilized powder. Ships stable at ambient temperature for short transit periods; store long-term at -20°C, protected from light and moisture. After reconstitution, store at 2-8°C and use within the window stated on the batch COA. Cold-chain and batch-specific handling details confirmed per lot. |
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
Hexarelin (INN examorelin) is a synthetic hexapeptide of the growth hormone-releasing peptide (GHRP) class, structurally derived from GHRP-6. In research models it acts as an agonist of the ghrelin / growth hormone secretagogue receptor (GHS-R1a). Its D-amino-acid substitutions confer resistance to enzymatic (DPP-IV) degradation relative to native ghrelin and first-generation GHRPs.
Documentation
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Hexarelin Acetate reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Every production lot includes a batch-linked COA reporting HPLC purity target (≥99%; actual result shown in lot documents) and identity confirmation by mass spectrometry (MS). COA and, where required, additional analytical data are provided per batch on request.
Standard catalog formats are 2mg and 5mg lyophilized vials, with a minimum order quantity of 50 kits (500 vials). Custom fill weights and bulk peptide quantities are quoted on RFQ.
Yes. We manufacture to private-label and OEM specifications, including custom vial fill weight, labeling, and packaging. Branding and documentation requirements are scoped per project.
The lyophilized peptide tolerates ambient temperatures during transit and is best held at -20°C, protected from light and moisture, for long-term storage. Cold-chain shipping options are available on request.
Yes. All material is supplied strictly for laboratory research, analytical, and manufacturing use only, not for consumer or veterinary consumption or applied use. Buyers are responsible for compliance with applicable regulations in their jurisdiction.
Related compounds